about
Genetic variation in healthy oldest-oldAnalysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesCooperative epigenetic modulation by cancer amplicon genesChronic active B-cell-receptor signalling in diffuse large B-cell lymphomaFrequent mutation of histone-modifying genes in non-Hodgkin lymphomaMolecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysMolecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphomaThe use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture CollectionConfirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayThe revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPOncogenically active MYD88 mutations in human lymphomaMHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersEtiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectCircos: an information aesthetic for comparative genomicsMantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome.Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21.Alemtuzumab in clinical practice: a British Columbia experience.Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.De novo transcriptome assembly with ABySS.Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaCorrelations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.Active idiotypic vaccination versus control immunotherapy for follicular lymphomaAutomated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.Lymphoma of the skin.Genetic variation in cell death genes and risk of non-Hodgkin lymphomaEnteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphomaExpression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)
P50
Q21143740-DDE976B4-020B-4D42-A948-CFBA49506C4AQ24170413-8A843E55-21EC-4C9E-8231-5BD8D80740F3Q24608701-63086F0C-5B93-44CD-BFA1-FD14A700CB6EQ24613755-2B3923F4-223F-4547-8EA3-D4880668E6D3Q24630610-5CEF850B-330C-4C45-9796-6A48138FA83CQ24652565-0097114B-BEE6-4B1D-99DD-0F1EE547117CQ24672476-B3908819-75C5-4F51-9B81-6410B7524FB2Q27824784-42D4027B-477F-4910-9072-301854F9F914Q27851546-51399B9D-802E-4550-90CC-400FE7AE5192Q27851699-AB6DACF3-3994-4888-85E5-6D078FF4ADD2Q27853195-1B8954D9-3CDA-4394-BF0E-87FBB2D4B400Q27913808-67C80B71-7D58-4F2F-9E5C-3A7E3B23B36EQ28204313-0AC32DCD-B394-4546-8F75-4EA0D5E9EB1DQ28274089-A08A598D-4241-4319-B971-3F705C9DC07AQ28301648-27C2DDC4-DFE6-484C-92A3-FFBF793E5DA2Q28306431-82692F94-00C0-4940-861F-74F3DA688651Q28393769-381AEABA-E8A9-46A6-9C7E-D182EF416FD2Q29547653-4AA8B625-91F6-42A7-BE0B-C3803DF392ADQ30452448-D06EBDDA-44A4-454D-BB2F-01316CEA4C70Q30819544-55BAA658-2443-4DFF-8B38-BE34E560E6EFQ30886820-6FB78BF7-85B5-4E53-8F39-9F05C5BF811FQ33163524-A1B65BB2-4A27-45D5-A3CF-52A1DEFED064Q33199914-E77789CD-D8B8-4F8F-A664-0F53195B1DCDQ33378464-FE309600-2522-48DC-8691-8447556518C6Q33401346-4D7C116D-B6CD-47E8-AEBA-B46623122258Q33467690-C0C52AD2-83F5-4433-BFF8-39A058838BC2Q33585243-ED39A675-2F16-40ED-BC65-C84C07DF08CCQ33587666-6C323A42-A04C-4397-905B-55FC4C2FFC5EQ33691505-64D8BEA8-668D-4533-AB1B-F53EC3C6ED93Q33875380-73A8F7DD-D68A-4B53-A365-91CFF3A410D9Q34147379-A20B1660-F30F-4416-ABFA-D7B70FBDEE96Q34160346-49F0DF38-6F72-44C9-98B8-81200F81820AQ34162892-9977ED08-187A-44A9-8ACE-5ECD13E37EA2Q34184665-8EEEB72B-17CA-4824-B762-6467945EB0B7Q34270046-D9AC1421-D724-49A6-9EB5-0412EF3718E0Q34393991-2E6BC23F-4296-4600-B669-0A8A7730C3FDQ34407534-4CF16E54-8E72-4483-865B-6E65D8D071BAQ34589970-6F4D0220-6C86-4DAB-A1E2-730A8A3672A7Q34628392-18C03D27-0895-43B8-83A6-1B99CF50F02AQ34645722-33471FD4-7795-42A8-A1B0-C9971E7BE139
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joseph M Connors
@ast
Joseph M Connors
@en
Joseph M Connors
@es
Joseph M Connors
@nl
Joseph M Connors
@sl
type
label
Joseph M Connors
@ast
Joseph M Connors
@en
Joseph M Connors
@es
Joseph M Connors
@nl
Joseph M Connors
@sl
prefLabel
Joseph M Connors
@ast
Joseph M Connors
@en
Joseph M Connors
@es
Joseph M Connors
@nl
Joseph M Connors
@sl
P106
P21
P31
P496
0000-0002-1361-7531
P569
2000-01-01T00:00:00Z